SCHEMBL7070033

SCHEMBL7070033

O=CC(Br)(Br)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
GSK3B P49841 2/20 0.43
CYP1A2 P05177 1/20 0.43
PTPN1 P18031 1/20 0.43
KIF11 P52732 4/20 0.42
EPHX2 P34913 1/20 0.41
ORAI1 Q96D31 1/20 0.41
ORAI2 Q96SN7 1/20 0.41
ORAI3 Q9BRQ5 1/20 0.41
TRPV6 Q9H1D0 1/20 0.41
MGLL Q99685 1/20 0.41
FBP1 P09467 1/20 0.41
BACE1 P56817 1/20 0.41
SRD5A2 P31213 1/20 0.40
HDAC3 O15379 1/20 0.39
ADAM17 P78536 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3361280 0.80 CES2 (0.47) CES2ALDH1A1TSHRMGLLFBP1
SCHEMBL3364629 0.79 KCNN4 (0.43) CES2CES1ALDH1A1PTPN1
SCHEMBL4392163 0.79 CES2 (0.46) CES2CES1ALDH1A1TSHRGSK3B
SCHEMBL63468 0.76 ALDH1A1 (0.67) CES2CES1ALDH1A1TSHRKIF11
SCHEMBL3365770 0.76 CYP2A6 (0.44) CES2CES1ALDH1A1CYP1A2
SCHEMBL28318087 0.75 CES2 (0.43) CES2CES1ALDH1A1TSHRGSK3B
SCHEMBL61631 0.74 CYP1A2 (0.54) CES2CES1ALDH1A1TSHRCYP1A2
SCHEMBL3366400 0.74 TSHR (0.48) ALDH1A1TSHRCYP1A2KIF11SRD5A2
SCHEMBL3424511 0.74 HSD17B10 (0.46) CES2CES1ALDH1A1TSHR
Formic Acid SCHEMBL31514292 0.73 CES2 (0.46) CES2CES1GSK3BCYP1A2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055479-A1 COMPOUNDS AND THEIR THERAPEUTIC USE RELATED TO THE PHOSPHORYLATING ACTIVITY OF THE ENZYME GSK-3 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2003-07-10 WO disclosed